Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Seres Therapeutics (MCRB) Depreciation and Depletion: 2022-2024

Historic Depreciation and Depletion for Seres Therapeutics (MCRB) over the last 3 years, with Dec 2024 value amounting to $989,000.

  • Seres Therapeutics' Depreciation and Depletion was N/A to $333,000 in Q3 2024 from the same period last year, while for Sep 2024 it was $1.5 million, marking a year-over-year change of. This contributed to the annual value of $989,000 for FY2024, which is 51.02% down from last year.
  • According to the latest figures from FY2024, Seres Therapeutics' Depreciation and Depletion is $989,000, which was down 51.02% from $2.0 million recorded in FY2023.
  • In the past 5 years, Seres Therapeutics' Depreciation and Depletion registered a high of $2.0 million during FY2023, and its lowest value of $989,000 during FY2024.
  • Moreover, its 3-year median value for Depreciation and Depletion was $1.5 million (2022), whereas its average is $1.5 million.
  • In the last 5 years, Seres Therapeutics' Depreciation and Depletion spiked by 38.38% in 2023 and then crashed by 51.02% in 2024.
  • Yearly analysis of 3 years shows Seres Therapeutics' Depreciation and Depletion stood at $1.5 million in 2022, then soared by 38.38% to $2.0 million in 2023, then slumped by 51.02% to $989,000 in 2024.